Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Bressel

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Breast Cancer Research and Treatment|February 25, 2016
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and managementIan M Collins, Adrian Bickerstaffe, Thilina Ranaweera, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2021
Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group StudyDanny Rischin, Madeleine King, Lizbeth Kenny, et al.
Contemporary Clinical Trials Communications|May 11, 2023
NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trialMuhammad Ali, Simon Wood, David Pryor, et al.
JMIR Formative Research|January 27, 2019
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability TestingLouisa L Lo, Ian M Collins, Mathias Bressel, et al.
BMJ Open|December 11, 2020
Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancerNicholas Bucknell, Nicholas Hardcastle, Price Jackson, et al.
Annals of Surgical Oncology|February 26, 2026
Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients with Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 TrialEyal Mor, Sameer Apte, Mathias Bressel, et al.
Annals of Surgical Oncology|March 16, 2026
ASO Visual Abstract: Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients With Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 TrialEyal Mor, Sameer Apte, Mathias Bressel, et al.
Contemporary Clinical Trials Communications|January 25, 2021
A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocolDavid Pryor, Mathias Bressel, Nathan Lawrentschuk, et al.
The New England Journal of Medicine|March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell LymphomaConstantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
The Medical Journal of Australia|January 11, 2024
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort studyLuke S McLean, Annette M Lim, Mathias Bressel, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|February 25, 2016
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and managementIan M Collins, Adrian Bickerstaffe, Thilina Ranaweera, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2021
Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group StudyDanny Rischin, Madeleine King, Lizbeth Kenny, et al.
Contemporary Clinical Trials Communications|May 11, 2023
NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trialMuhammad Ali, Simon Wood, David Pryor, et al.
JMIR Formative Research|January 27, 2019
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability TestingLouisa L Lo, Ian M Collins, Mathias Bressel, et al.
BMJ Open|December 11, 2020
Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancerNicholas Bucknell, Nicholas Hardcastle, Price Jackson, et al.
Annals of Surgical Oncology|February 26, 2026
Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients with Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 TrialEyal Mor, Sameer Apte, Mathias Bressel, et al.
Annals of Surgical Oncology|March 16, 2026
ASO Visual Abstract: Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients With Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 TrialEyal Mor, Sameer Apte, Mathias Bressel, et al.
Contemporary Clinical Trials Communications|January 25, 2021
A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocolDavid Pryor, Mathias Bressel, Nathan Lawrentschuk, et al.
The New England Journal of Medicine|March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell LymphomaConstantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
The Medical Journal of Australia|January 11, 2024
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort studyLuke S McLean, Annette M Lim, Mathias Bressel, et al.
Pageof 14